Regulatory guide

Cell-therapy due diligence for patients in the UAE

A country-specific starting point for checking product authorisation, trial oversight and cross-border follow-up. This page does not rank providers or recommend medical travel.

What the regulator can confirm

The United Arab Emirates regulates different parts of cell and tissue activity through federal and emirate-level authorities. The MOHAP regulation for cord-blood and stem-cell storage centres concerns licensing and operation of those centres; it is not proof that every therapeutic use of stored or processed cells is authorised. Depending on location and activity, MOHAP, the Dubai Health Authority or the Department of Health Abu Dhabi may be relevant.

Ask the provider which authority regulates the facility, product, manufacturing step and proposed indication. Obtain the current licence or authorisation number and scope, not a logo or general certificate. If treatment is described as research, request the authorised protocol, ethics approval, sponsor, insurance and public results plan.

Evidence to request before treatment

QuestionDocument or identifierWhy it matters
What exactly is administered?Product name, cell source, processing, dose and routeEvidence and legal status are product- and indication-specific.
What is the legal route?Marketing authorisation, authorised trial number, or named exemption and authorityA clinic licence or registry listing does not by itself authorise a product.
Who manufactures it?Legal manufacturer, site and authorisation scopeGeneral references to GMP are not a substitute for a current, applicable record.
How are harms managed?Consent form, adverse-event plan, insurance and emergency contactExperimental status does not remove the duty to disclose and manage risk.
What happens after travel?Written follow-up plan and named clinicianCross-border care can complicate continuity and reporting.
If the provider will not identify the exact product, legal route and responsible manufacturer in writing, pause before paying or travelling.

Conditions compared

Educational regulatory orientation, reviewed in 2026. Verify current records directly with the authority and seek independent medical advice.

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information